New prognostic biomarkers in multiple myeloma
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Multiple myeloma is a malignant neoplastic disease, characterized by uncontrolled proliferation and accumulation of plasma cells in the bone marrow, which is usually connected with production of a monoclonal protein. It is the second most common hematologic malignancy. It constitutes approximately 1% of all cancers and 10% of hematological malignancies. Despite the huge progress that has been made in the treatment of multiple myeloma in the past 30 years including the introduction of new immunomodulatory drugs and proteasome inhibitors, it is still an incurable disease. According to current data, the five-year survival rate is 45%. Multiple myeloma is a very heterogeneous disease with a very diverse clinical course, which is expressed by differences in effectiveness of therapeutic strategies and ability to develop chemoresistance. This diversity implies the need to define risk stratification factors that would help to create personalized and optimized therapy and thereby improve treatment outcomes. Prognostic markers that aim to objectively evaluate the risk of a poor outcome, relapse and the patient’s overall outcome are useful for this purpose. The existing, widely used prognostic classifications, such as the Salmon-Durie classification or ISS, do not allow for individualization of treatment. As a result of the development of diagnostic techniques, especially cytogenetics and molecular biology, we were able to discover a lot of new, more sensitive and specific prognostic factors. The paper presents recent reports on the role of molecular, cytogenetic and biochemical alterations in pathogenesis and prognosis of the disease.
Authors and Affiliations
Aneta Szudy-Szczyrek, Michał Szczyrek, Maria Soroka-Wojtaszko, Marek Hus
Keywords
Related Articles
- EP ID EP206126
- DOI -
- Views 149
- Downloads 0
Overproduction of gastric mucus as a mechanism of stomach’s mucosa protection during energy drinks consumption in Wistar rats
Aim: Energy drinks are the most consumed, socially accepted stimulants in the world. They are drunk by drivers and students, and more often also by adolescents and children. It has been noted that some adverse events are...
Zmiana elektropotencjałów w jamie ustnej po zastosowaniu impulsowego pola magnetycznego z zakresu ELF
Pojawiające się w jamie ustnej elektropotencjały nie są obojętne, gdyż mogą wywoływać różne schorzenia oraz powodować występowanie subiektywnych nieprzyjemnych odczuć, których leczenie jest bardzo trudne. Celem badań był...
Perspectives on the pharmacotherapy of diseases extending with advanced oxidation protein products participation
In the view of constantly increasing number of reports about participation of advanced oxidation protein products (AOPPs) in pathogenesis of many diseases as well as in the pathomechanism of their biochemical disturbance...
Methylprednisolone– acute spinal cord injury, benefits or risks?
Methylprednisolone is a synthetic glucocorticoid with a potent and long-acting anti-inflammatory, antiallergic and immunosuppressant. Its mechanism of action of methylprednisolone is the result of many cellular changes....
The influence of a thyroxine supplemented diet on selected hepatic redox equilibrium markers, liver morphology and the serum lipid profile in rats treated with doxorubicin
Introduction: Cytotoxicity of doxorubicin (DOX) – an anticancer drug, mostly results from reactive oxygen species (ROS) generation. Some enzymes catalyzing this process and enzymes of antioxidant defense are regulated by...